Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017

◆英語タイトル:Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017
◆商品コード:DATA904C3222
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
Summary

Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream business supplies and trades crude oil and products, refines oil, and produces and markets petroleum products, liquefied natural gas (LNG) and petrochemicals. Repsol operates refineries in Spain and Peru. The company markets fuels directly through a network of retail stations and sales distributors. It also carries out generation, transmission, distribution and commercialization of electricity. The company has presence in Europe, Latin America, North America, Africa, Asia and Oceania. Repsol is headquartered in Madrid, Spain.

Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational metrics, analysis and provides a strategic insight into the company. The report provides an annual and quarterly overview of oil and gas reserves and production, changes in reserves, costs incurred and results of oil and gas operations, acreage and well details, share price performance and key valuation metrics.

Scope

The report provides in-depth analysis and insights into companies’ capital spending, revenues, oil and gas reserves, production, and performance measures. Its scope includes the following –
- The report provides detailed and unique insight information on the key operational metrics. It gives a comprehensive overview of oil and gas production and reserves, costs incurred and results of oil and gas operations, acreage and well details and other performance metrics.
- Provides details with respect to the company’s oil and gas reserves and production information by country. It further consists of in-depth information on the company’s expenditures in relation to the acquisition, exploration and development activities; developed and undeveloped acreage position; key costs and revenue information; and performance metrics of the company as disclosed in its annual reports and regulatory filings.
- Provides a comprehensive overview of the company’s share price performance and key valuation metrics such as market capitalization, enterprise value, EV/Production ($boe/d) and EV/Proved Reserve ($/boe)
- Provides information on key operational and financial metrics on an annual and quarterly basis. The annual information provided is for a five-year period and the quarterly information is for the last five quarters.

*Note:

1. The scope mentioned above is generic and may not apply to all the companies. The report is based on the information disclosed by the companies in their annual and quarterly reports, regulatory filings and other company documents and sources.
2. Quarterly information is provided only for the companies that are December ending and files quarter reports and documents.
3. There can be cases where countries/regions data column/Charts will be blank. This can be due to the fact that the company might have discontinued the reporting of those countries/regions. Information that is not disclosed by the company may not be available in the report.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
- Be up-to-date with the latest information and in-depth analysis of the operational metrics of the company.
- Identify M&A targets from up-to-date information and in-depth analysis on financial and operational metrics of your competitors.
- Rank your performance against other companies in the exploration and production (E&P) sector using operational and financial benchmarking metrics.
- Formulate your strategies based on in-depth analysis of your competitors’ financial and operational data.
- Exploit the strengths and weakness of your closest competitors by comparing and analyzing their financial and operational metrics.
- Establish relative performance among the industry’s players based on key operational and financial measures.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Company Snapshot 7
Key Information 7
Company Overview 7
Repsol SA, Valuation and Financial Data 8
Repsol SA, Share Price Performance 8
Share Price Performance, Q4, 2016-Q4, 2017 8
Repsol SA, Key Valuation Metrics 9
Key Valuation Metrics, Q4, 2016-Q4, 2017 9
Repsol SA, Quarterly E&P Costs Trends 10
Upstream Capital Expenditure, Q4, 2016-Q4, 2017 10
Repsol SA, Quarterly Production Trends 11
Repsol SA, Total Oil and Gas Production 11
Total Crude Oil and Natural Gas Production Trend, Q4, 2016-Q4, 2017 11
Total Crude Oil & Natural Gas Production, By Country/Region, Q4, 2016-Q4, 2017 13
Repsol SA, Crude Oil Production 14
Total Crude Oil Production Trend, Q4, 2016-Q4, 2017 14
Crude Oil Production, By Country/Region, Q4, 2016-Q4, 2017 15
Repsol SA, Natural Gas Production 16
Total Natural Gas Production Trend, Q4, 2016-Q4, 2017 16
Natural Gas Production, By Country/Region, Q4, 2016-Q4, 2017 17
Repsol SA, Valuation and Financial Data, 2013-2017 18
Repsol SA, Share Price Performance, 2013-2017 18
Share Price Performance, 2013-2017 18
Key Valuation Metrics, 2013-2017 19
Repsol SA, Production and Reserves Trends 20
Total Oil and Gas, Reserves and Production 20
Total Crude Oil and Natural Gas Production and Reserves Trend, 2013-2017 20
Total Crude Oil & Natural Gas Production and Reserves By Country/Region, 2013-2017 22
Total Crude Oil and Natural Gas Reserve Changes, 2013-2017 24
Crude Oil/Liquids Production and Reserve 25
Crude Oil/Liquids Production and Reserve Trend, 2013-2017 25
Crude Oil Production and Reserves By Country/Region, 2013-2017 26
Crude Oil/Liquids Reserve Changes, 2013-2017 28
Natural Gas Production and Reserve 29
Natural Gas Production and Reserve Trend, 2013-2017 29
Natural Gas Production and Reserves, By Country/Region, 2013-2017 31
Natural Gas Reserve Changes, 2013-2017 33
Total Crude Oil and Natural Gas Reserves Life Index 34
Total Crude Oil and Natural Gas Reserves Life Index, 2013-2017 34
Total Crude Oil and Natural Gas Reserves Life Index, By Country/Region, 2013-2017 35
Repsol SA, E&P Costs Trends 38
Allocation of the Upstream Capital Expenditure 38
Upstream Capital Expenditure, 2013-2017 38
Acquisition Costs By Country/Region, 2013-2017 40
Exploration and Development Costs, By Country/Region, 2013-2017 42
Oil and Gas Cost Per boe, US$/boe 44
Oil and Gas Cost Per boe, US$/boe, 2013-2017 44
Oil and Gas Cost Per boe, US$/boe, By Country/Region, 2013-2017 46
Repsol SA, Reserve Replacement Ratio 49
Oil and Gas Production Replacement Ratio 49
Oil and Gas Production Replacement Ratio, 2013-2017 49
Oil and Gas Production Replacement Ratio, By Country/Region, 2013-2017 51
Repsol SA, Results of Oil & Gas Operations Trend 57
Oil and Gas Revenue and Expenses 57
Oil and Gas Revenue and Expenses, 2013-2017 57
Oil and Gas Revenue and Expenses, By Country/Region, 2013-2017 59
Oil and Gas Revenue and Expenses, Per boe 66
Oil and Gas Revenue and Expenses, By boe, 2013-2017 66
Oil and Gas Revenue and Expenses Per boe, By Country/Region, 2013-2017 67
Oil and Gas Performance Metrics 73
Repsol SA, Land Holdings and Well Data 74
Developed and Undeveloped Acreage 74
Gross and Net Developed and Undeveloped Acreage, 2013-2017 74
Gross and Net Developed and Undeveloped Acreage, By Country/Region, 2013-2017 75
Well Statistics 80
Producible Oil and Gas Well, 2013-2017 80
Producible Oil and Gas Well, By Country/Region, 2013-2017 81
Recent Developments 85
Repsol SA – Recent Developments 85
Aug 01, 2018: PetroVietnam signs gas deal with Japan amidst tensions with China 85
Jul 26, 2018: Repsol earnings increase 46% to 1.546 billion euros 85
Jul 26, 2018: Repsol announces management team restructuring 89
Jul 24, 2018: Red Emperor Resources announces quarterly reports for period ending 30 June 2018 and appendix 5B 90
Jul 18, 2018: MOECO: Acquisition of interest in southeast jambi block onshore Indonesia 92
Jul 18, 2018: Lion executes east seram PSC 93
Jul 06, 2018: PSA: Audit Of Repsol – Gyda 94
Jun 25, 2018: Otto To Drill 400 Million Barrel Nanushuk Oil Prospect On Alaska North Slope In Early 2019 95
Jun 13, 2018: 88 Energy Provides Operations Update 98
Appendix 100
Methodology 100
Coverage 100
Secondary Research 100
Primary Research 101
Data Information Sources 101
Company Source 101
SEC/Other Regulatory Filings 101
Other Sources 101
Expert Panel Validation 101
Data Definition 101
Oil and Gas Reserves 101
Units of Measure 102
About GlobalData 103
Disclosure 103
Disclaimer 103

List of Tables
Table 1: Repsol SA, Key Facts 7
Table 2: Repsol SA, Share Price Performance, Q4, 2016-Q4, 2017 8
Table 3: Repsol SA, Key Valuation Metrics, Q4, 2016-Q4, 2017 9
Table 4: Repsol SA, Upstream Capital Expenditure, Q4, 2016-Q4, 2017 10
Table 5: Repsol SA, Total Crude Oil and Natural Gas, Production, Q4, 2016-Q4, 2017 12
Table 6: Repsol SA, Total Oil & Gas Production, By Country/Region, mmboe, Q4, 2016-Q4, 2017 13
Table 7: Repsol SA, Total Crude Oil Production, mmbbl, Q4, 2016-Q4, 2017 14
Table 8: Repsol SA, Crude Oil Production, By Country/Region, mmbbl, Q4, 2016-Q4, 2017 15
Table 9: Repsol SA, Total Natural Gas Production, bcf, Q4, 2016-Q4, 2017 16
Table 10: Repsol SA, Natural Gas Production, By Country/Region, bcf, Q4, 2016-Q4, 2017 17
Table 11: Repsol SA, Share Price Performance, 2013-2017 18
Table 12: Repsol SA, Key Valuation Metrics, 2013-2017 19
Table 13: Repsol SA, Total Crude Oil and Natural Gas, Production and Reserves, mmboe, 2013-2017 21
Table 14: Repsol SA, Total Crude Oil & Natural Gas Production and Reserves, By Country/Region, mmboe, 2013-2017 23
Table 15: Repsol SA, Total Crude Oil and Natural Gas Reserve Changes, mmboe, 2013-2017 24
Table 16: Repsol SA, Crude Oil Production and Reserves Metrics, mmbbl, 2013-2017 25
Table 17: Repsol SA, Crude Oil Production and Reserves, By Country/Region, mmbbl, 2013-2017 27
Table 18: Repsol SA, Crude Oil Reserve Changes, mmbbl, 2013-2017 28
Table 19: Repsol SA, Natural Gas Production and Reserves Metrics, bcf, 2013-2017 30
Table 20: Repsol SA, Natural Gas Production and Reserves, By Country/Region, bcf, 2013-2017 32
Table 21: Repsol SA, Natural Gas Reserve Changes, bcf, 2013-2017 33
Table 22: Repsol SA, Oil and Gas Reserves Life Index, Years, 2013-2017 34
Table 23: Repsol SA, Oil and Gas Reserves Life Index, By Country/Region, Years, 2013-2017 37
Table 24: Repsol SA, Upstream Capital Expenditure, US$ mil, 2013-2017 39
Table 25: Repsol SA, Proved and Unproved Acquisition Costs, By Country/Region, US$ mil, 2013-2017 41
Table 26: Repsol SA, Exploration and Development Costs, By Country/Region, US$ mil, 2013-2017 43
Table 27: Repsol SA, Reserves Replacement, Finding and Development Costs, Finding Cost and Proved Acquisition Costs Per boe, US$/boe, 2013-2017 45
Table 28: Repsol SA, Reserves Replacement, Finding and Development Costs, Finding Cost and Proved Acquisition Costs Per boe, US$/boe, By Country/Region, 2013-2017 48
Table 29: Repsol SA, Oil and Gas Production Replacement Ratio, %, 2013-2017 49
Table 30: Repsol SA, 3-Year Wt.Avg. Oil and Gas Production Replacement Ratio, By Country/Region, %, 2013-2017 54
Table 31: Repsol SA, Revenue and Expenses, US$ mil, 2013-2017 58
Table 32: Repsol SA, Revenue and Expenses, By Country/Region, US$ mil, 2013-2017 63
Table 33: Repsol SA, Oil and Gas Revenue and Expenses, US$/boe, 2013-2017 66
Table 34: Repsol SA, Oil and Gas Revenue and Expenses, US$/boe, By Country/Region, 2013-2017 70
Table 35: Repsol SA, Oil and Gas Performance Metrics, 2013-2017 73
Table 36: Repsol SA, Land Holdings (Developed and Undeveloped Acreage), Acres, 2013-2017 74
Table 37: Repsol SA, Land Holdings (Developed and Undeveloped Acreage), By Country/Region, Acres, 2013-2017 77
Table 38: Repsol SA, Producible Oil and Gas Wells, 2013-2017 80
Table 39: Repsol SA, Producible Oil and Gas Wells, By Country/Region, 2013-2017 82

List of Figures
Figure 1: Repsol SA, Share Price Performance, EUR/Share, Q4, 2016-Q4, 2017 8
Figure 2: Repsol SA, Key Valuation Metrics, EV/Production ($/boed), EV/Proved Reserve ($/boe), Q4, 2016-Q4, 2017 9
Figure 3: Repsol SA, Upstream Capital Expenditure, US$ mil, Q4, 2016-Q4, 2017 10
Figure 4: Repsol SA, Total Crude Oil and Natural Gas, Production, mmboe, Q4, 2016-Q4, 2017 11
Figure 5: Repsol SA, Total Oil & Gas Production, By Country/Region, mmboe, Q4, 2016-Q4, 2017 13
Figure 6: Repsol SA, Total Crude Oil Production, mmbbl, Q4, 2016-Q4, 2017 14
Figure 7: Repsol SA, Crude Oil Production, By Country/Region, mmbbl, Q4, 2016-Q4, 2017 15
Figure 8: Repsol SA, Total Natural Gas Production, bcf, Q4, 2016-Q4, 2017 16
Figure 9: Repsol SA, Natural Gas Production, By Country/Region, bcf, Q4, 2016-Q4, 2017 17
Figure 10: Repsol SA, Share Price Performance, EUR/Share, 2013-2017 18
Figure 11: Repsol SA, Key Valuation Metrics, EV/Production ($/boed), EV/Proved Reserve (US$/boe), 2013-2017 19
Figure 12: Repsol SA, Total Crude Oil and Natural Gas, Production and Reserves, mmboe, 2013-2017 20
Figure 13: Repsol SA, Total Oil & Gas Reserves, End of Period, By Country/Region, mmboe, 2013-2017 22
Figure 14: Repsol SA, Total Oil & Gas Production, By Country/Region, mmboe, 2013-2017 22
Figure 15: Repsol SA, Total Crude Oil and Natural Gas Reserve Changes, mmboe, 2017 24
Figure 16: Repsol SA, Crude Oil Production and Reserves Metrics, mmbbl, 2013-2017 25
Figure 17: Repsol SA, Oil Reserves, End of Period, By Country/Region, mmbbl, 2013-2017 26
Figure 18: Repsol SA, Oil Production, By Country/Region, mmbbl, 2013-2017 26
Figure 19: Repsol SA, Crude Oil Reserve Changes, mmbbl, 2017 28
Figure 20: Repsol SA, Natural Gas Production and Reserves Metrics, bcf, 2013-2017 29
Figure 21: Repsol SA, Gas Reserves, End of Period, By Country/Region, bcf, 2013-2017 31
Figure 22: Repsol SA, Gas Production, By Country/Region, bcf, 2013-2017 31
Figure 23: Repsol SA, Natural Gas Reserve Changes, bcf, 2017 33
Figure 24: Repsol SA, Oil and Gas Reserves Life Index, Years, 2013-2017 34
Figure 25: Repsol SA, Gas Reserve Life Index, By Country/Region, Years, 2013-2017 35
Figure 26: Repsol SA, Oil & Gas Reserve Life Index, By Country/Region, Years, 2013-2017 35
Figure 27: Repsol SA, Oil Reserve Life Index, By Country/Region, Years, 2013-2017 36
Figure 28: Repsol SA, Upstream Capital Expenditure, US$ mil, 2013-2017 38
Figure 29: Repsol SA, Proved Acquisition Costs, By Country/Region, US$ mil, 2013-2017 40
Figure 30: Repsol SA, Unproved Acquisition Costs, By Country/Region, US$ mil, 2013-2017 40
Figure 31: Repsol SA, Development Costs, By Country/Region, US$ mil, 2013-2017 42
Figure 32: Repsol SA, Exploration Costs, By Country/Region, US$ mil, 2013-2017 42
Figure 33: Repsol SA, 3-Year Wt.Avg., Reserves Replacement, Finding and Development Costs, Finding Cost and Proved Acquisition Costs Per boe, US$/boe, 2013-2017 44
Figure 34: Repsol SA, Oil & Gas Finding & Development Cost/boe, 3-Year Average, By Country/Region, US$/boe, 2013-2017 46
Figure 35: Repsol SA, Oil & Gas Finding Cost per boe, 3-Year Average, By Country/Region, US$/boe, 2013-2017 46
Figure 36: Repsol SA, Reserve Replacement Cost per boe, 3-Year Average, By Country/Region, US$/boe, 2013-2017 47
Figure 37: Repsol SA, 3-Year Wt.Avg., Oil and Gas Production Replacement Ratio, %, 2013-2017 49
Figure 38: Repsol SA, 3-Year Wt. Avg. Gas F&D Production Replacement, By Country/Region, %, 2013-2017 51
Figure 39: Repsol SA, 3-Year Wt. Avg. Gas RRC Production Replacement, By Country/Region, %, 2013-2017 51
Figure 40: Repsol SA, 3-Year Wt. Avg. Oil & Gas F&D Production Replacement, By Country/Region, %, 2013-2017 52
Figure 41: Repsol SA, 3-Year Wt. Avg. Oil & Gas RRC Production Replacement, By Country/Region, %, 2013-2017 52
Figure 42: Repsol SA, 3-Year Wt. Avg. Oil F&D Production Replacement, By Country/Region, %, 2013-2017 53
Figure 43: Repsol SA, 3-Year Wt. Avg. Oil RRC Production Replacement, By Country/Region, %, 2013-2017 53
Figure 44: Repsol SA, Revenue and Expenses, US$ mil, 2013-2017 57
Figure 45: Repsol SA, Depreciation, Depletion and Amortization From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 59
Figure 46: Repsol SA, Exploration Expenses, By Country/Region, US$ mil, 2013-2017 59
Figure 47: Repsol SA, Income Tax Provision (Benefit) From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 60
Figure 48: Repsol SA, Net Income/ Loss From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 60
Figure 49: Repsol SA, Oil & Gas Revenue, By Country/Region, US$ mil, 2013-2017 61
Figure 50: Repsol SA, Profit (loss) Before Taxation From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 61
Figure 51: Repsol SA, Production Costs, By Country/Region, US$ mil, 2013-2017 62
Figure 52: Repsol SA, Total Expenses From Upstream Oil & Gas Operations, By Country/Region, US$ mil, 2013-2017 62
Figure 53: Repsol SA, Oil and Gas Revenue and Expenses, US$/boe, 2013-2017 66
Figure 54: Repsol SA, Exploration Expenses per boe, By Country/Region, $/boe, 2013-2017 67
Figure 55: Repsol SA, Income Tax/(Benefit) per boe, By Country/Region, $/boe, 2013-2017 67
Figure 56: Repsol SA, Lifting Cost per boe, By Country/Region, $/boe, 2013-2017 68
Figure 57: Repsol SA, Annual Net Income per boe, By Country/Region, $/boe, 2013-2017 68
Figure 58: Repsol SA, Oil & Gas Revenue per boe, By Country/Region, $/boe, 2013-2017 69
Figure 59: Repsol SA, Total DD&A per boe, By Country/Region, $/boe, 2013-2017 69
Figure 60: Repsol SA, Total Revenue per boe, By Country/Region, $/boe, 2013-2017 70
Figure 61: Repsol SA, Oil and Gas Performance Metrics, 2013-2017 73
Figure 62: Repsol SA, Land Holdings (Developed and Undeveloped Acreage), Acres, 2013-2017 74
Figure 63: Repsol SA, Total Gross Undeveloped Acreage, By Country/Region, Acres, 2013-2017 75
Figure 64: Repsol SA, Total Net Undeveloped Acreage, By Country/Region, Acres, 2013-2017 75
Figure 65: Repsol SA, Total Gross Developed Acreage, By Country/Region, Acres, 2013-2017 76
Figure 66: Repsol SA, Total Net Developed Acreage, By Country/Region, Acres, 2013-2017 76
Figure 67: Repsol SA, Producible Oil and Gas Wells, 2013-2017 80
Figure 68: Repsol SA, Gross Productive Gas Wells, By Country/Region, Number, 2013-2017 81
Figure 69: Repsol SA, Gross Productive Oil & Gas Wells, By Country/Region, Number, 2013-2017 81
Figure 70: Repsol SA, Gross Productive Oil Wells, By Country/Region, Number, 2013-2017 82

★海外企業調査レポート[Repsol SA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務分析
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • Taiho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group focuses on the development, production and marketing of pharmaceutical products in the fields of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic age …
  • TranSystems Corporation:企業の戦略・SWOT・財務情報
    TranSystems Corporation - Strategy, SWOT and Corporate Finance Report Summary TranSystems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AEON Credit Service (M) Berhad:企業の戦略・SWOT・財務情報
    AEON Credit Service (M) Berhad - Strategy, SWOT and Corporate Finance Report Summary AEON Credit Service (M) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Wm Morrison Supermarkets PLC:企業のM&A・事業提携・投資動向
    Wm Morrison Supermarkets PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wm Morrison Supermarkets PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Department of Defense Education Activity:企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • NKT AS (NKT):企業の財務・戦略的SWOT分析
    NKT AS (NKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Cleanaway Waste Management Ltd (CWY):企業の戦略的SWOT分析
    Cleanaway Waste Management Ltd (CWY) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析
    Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Clean Diesel Technologies Inc (CDTI):企業の財務・戦略的SWOT分析
    Summary Clean Diesel Technologies Inc (CDTI) is a clean technology company that manufactures and distributes heavy duty diesel and light duty vehicle emissions control systems and products to automakers and retrofitters. The company's products include catalyst products, heavy duty diesel products, a …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nathan’s Famous, Inc. (NATH):企業の財務・戦略的SWOT分析
    Nathan's Famous, Inc. (NATH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Perfint Healthcare Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Perfint Healthcare Pvt Ltd (Perfint), formerly Perfint Engineering Services Pvt Ltd is a medical device company that develops image guided interventional products on onchology and pain care. The company’s products comprise MAXIO, stereotactic accessory to a Computed Tomography system; ROBIO …
  • Korea South-East Power Co Ltd:企業の戦略的SWOT分析
    Korea South-East Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • CytoSorbents Corp (CTSO):企業の財務・戦略的SWOT分析
    Summary CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriou …
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務情報
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆